Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection
Open Access
- 25 January 2008
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 12 (1) , R28
Abstract
Background: Little is known about the most severe forms of Pneumocystis jiroveci pneumonia (PCP) in HIV-negative as compared with HIV-positive patients. Improved knowledge about the differential characteristics and management modalities could guide treatment based on HIV status. Methods: We retrospectively compared 72 patients (73 cases, 46 HIV-positive) admitted for PCP from 1993 to 2006 in the intensive care unit (ICU) of a university hospital. Results: The yearly incidence of ICU admissions for PCP in HIV-negative patients increased from 1993 (0%) to 2006 (6.5%). At admission, all but one non-HIV patient were receiving corticosteroids. Twenty-three (85%) HIV-negative patients were receiving an additional immunosuppressive treatment. At admission, HIV-negative patients were significantly older than HIV-positive patients (64 [18 to 82] versus 37 [28 to 56] years old) and had a significantly higher Simplified Acute Physiology Score (SAPS) II (38 [13 to 90] versus 27 [11 to 112]) but had a similar PaO2/FiO2 (arterial partial pressure of oxygen/fraction of inspired oxygen) ratio (160 [61 to 322] versus 183 [38 to 380] mm Hg). Ventilatory support was required in a similar proportion of HIV-negative and HIV-positive cases (78% versus 61%), with a similar proportion of first-line non-invasive ventilation (NIV) (67% versus 54%). NIV failed in 71% of HIV-negative and in 13% of HIV-positive patients (p < 0.01). Mortality was significantly higher in HIV-negative than HIV-positive cases (48% versus 17%). The HIV-negative status (odds ratio 3.73, 95% confidence interval 1.10 to 12.60) and SAPS II (odds ratio 1.07, 95% confidence interval 1.02 to 1.12) were independently associated with mortality at multivariate analysis. Conclusion: The yearly incidence of ICU admissions for PCP in HIV-negative patients in our unit increased from 1993 to 2006. The course of the disease and the outcome were worse in HIV-negative patients. NIV often failed in HIV-negative cases, suggesting that NIV must be watched closely in this population.Keywords
This publication has 32 references indexed in Scilit:
- Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled TrialsMayo Clinic Proceedings, 2007
- Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapyThorax, 2006
- Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive studyJournal of Infection, 2003
- Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus (HIV)—Positive and HIV-Negative Immunocompromised PatientsClinical Infectious Diseases, 1999
- Pneumocystis carinii pneumonia requiring intensive care managementCritical Care Medicine, 1999
- Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumoniaEuropean Respiratory Journal, 1995
- Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shockCritical Care Medicine, 1994
- Severe Pneumocystis carinii pneumonia produces a hyperdynamic profile similar to bacterial pneumonia with sepsisCritical Care Medicine, 1994
- Continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severePneumocystis carinii pneumoniaIntensive Care Medicine, 1992
- ROLE FOR STEROIDS IN TREATMENT OF PNEUMOCYSTIS CARINII PNEUMONIA IN AIDSThe Lancet, 1987